Cefalotin

Jump to: navigation, search
Cefalotin
Cefalotin.png
Clinical data
AHFS/Drugs.comInternational Drug Names
MedlinePlusa682860
Pregnancy
category
  • AU: A
  • US: B (No risk in non-human studies)
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
Pharmacokinetic data
Bioavailabilityn/a
Protein binding65 to 80%
MetabolismHepatic
Elimination half-life30 minutes to 1 hour
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H16N2O6S2
Molar mass396.44 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Cefalotin

Articles

Most recent articles on Cefalotin

Most cited articles on Cefalotin

Review articles on Cefalotin

Articles on Cefalotin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefalotin

Images of Cefalotin

Photos of Cefalotin

Podcasts & MP3s on Cefalotin

Videos on Cefalotin

Evidence Based Medicine

Cochrane Collaboration on Cefalotin

Bandolier on Cefalotin

TRIP on Cefalotin

Clinical Trials

Ongoing Trials on Cefalotin at Clinical Trials.gov

Trial results on Cefalotin

Clinical Trials on Cefalotin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefalotin

NICE Guidance on Cefalotin

NHS PRODIGY Guidance

FDA on Cefalotin

CDC on Cefalotin

Books

Books on Cefalotin

News

Cefalotin in the news

Be alerted to news on Cefalotin

News trends on Cefalotin

Commentary

Blogs on Cefalotin

Definitions

Definitions of Cefalotin

Patient Resources / Community

Patient resources on Cefalotin

Discussion groups on Cefalotin

Patient Handouts on Cefalotin

Directions to Hospitals Treating Cefalotin

Risk calculators and risk factors for Cefalotin

Healthcare Provider Resources

Symptoms of Cefalotin

Causes & Risk Factors for Cefalotin

Diagnostic studies for Cefalotin

Treatment of Cefalotin

Continuing Medical Education (CME)

CME Programs on Cefalotin

International

Cefalotin en Espanol

Cefalotin en Francais

Business

Cefalotin in the Marketplace

Patents on Cefalotin

Experimental / Informatics

List of terms related to Cefalotin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefalotin (INN) (pronounced /sɛfəˈlotən/, /kɛfə-/) or cephalothin (USAN) (/sɛfəˈloθən/, /kɛfə-/) is a first-generation cephalosporin antibiotic. It was the first cephalosporin marketed and continues to be widely used. It is an intravenously-administered agent with a similar antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cefalotin sodium is commonly marketed under the trade name Keflin (Lilly).

See also



Linked-in.jpg